| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -11K | 100% | $13.99 | -$154K |
| Net | -1 | -11K | -100% | -$154K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Alexander J. Denner | 10%+ Owner | $117M | Jun 15, 2023 | ||
| George Bickerstaff | Director | $2.2M | Apr 25, 2022 | ||
| Jules Haimovitz | Director | $2.11M | Jun 17, 2024 | ||
| Kostas D. Odysseas | Director | $1.98M | Jun 17, 2024 | ||
| Mark DiPaolo | Director | $1.91M | Jun 17, 2024 | ||
| Sarah Schlesinger | Director | $1.91M | Jun 17, 2024 | ||
| Deborah Birx | Director | $947K | May 22, 2023 | ||
| Marianne Zhen | Chief Accounting Officer | $843K | -$154K | -15.4% | Aug 20, 2024 |
| Sapna Srivastava | Director | $711K | Jun 17, 2024 | ||
| Matthew Ronsheim | Officer | $653K | May 20, 2024 | ||
| Derek Small | Director | $374K | Jun 17, 2024 | ||
| Pavel Raifeld | Chief Executive Officer | $184K | Mar 5, 2024 | ||
| Stephen Basso | Chief Financial Officer | $180K | Mar 5, 2024 | ||
| Margaret Koziel | Chief Medical Officer | Jul 31, 2023 | |||
| GSK plc | 10%+ Owner | May 20, 2021 | |||
| Larry Edwards | CEO of La Jolla Pharmaceutical | Aug 22, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|